TET2 and Immunodeficiency: In another study, patients homozygous for LoF TET2 variants showed severe immunodeficiency, lymphadenopathy, hepatosplenomegaly, developmental delay, autoimmunity, and B-cell or T-cell lymphoma (Stremenova Spegarova et al., 2020).